Clinical trials often fail to reach desired goals due to poor recruitment outcomes, including low participant turnout, high recruitment cost, or poor representation of minorities.
As a principal investigator in the early 1980s at University Hospital in Peru, I used to receive instructions and queries from the study team through a Telex machine.
Lessons learned from the recruitment of colorectal cander patients into clinical trials.
The current initiatives and a historical overview of the clinical trial landscape.
A simple but overlooked way to save millions of dollars during new drug development.
How the application of evolving M&S models are transforming full-research design strategies.
How the application of evolving M&S models are transforming full-research design strategies.
The region has an appropriate population size, solid infrastructure, experienced nvestigators, and short timelines.
A simple but overlooked way to save millions of dollars during new drug development.
A clearly defined set of performance measures is an integral part of the central laboratory selection and management process.
Search-engine data offers window to public consciousness around clinical trial research, participation.
As funding for clinical research trials decreases and sponsors of clinical studies are under increasingly stringent timelines to obtain FDA approval and get new therapies to market, the need increases for well-managed, efficient, and effective clinical trial sites.
Medicines development and clinical research are among the most heavily regulated activities on a global basis.
There are significant challenges facing the pharmaceutical and contract research organization (CRO) industries in relation to patient recruitment of clinical trials and the need to implement new strategies to finally overcome what has been called ‘the most difficult and challenging aspect of clinical trials.’
Going paperless can help an IRB quickly collaborate, share documents, and review protocols.
As the importance of translational research continues to grow, research institutions are exploring other options to remain competitive players in the academic clinical research arena.
Pharmaceutical sponsors conducting clinical trials in the Asia Pacific region have a rare opportunity at hand...
Partnership formation is the new trend in common technical document development.
Despite the growing need for pediatric-approved medications, clinical trial enrollment for pediatrics remains challenging.
Often overlooked in early evaluation of RBM are the tools and technologies required for successful implementation. Without the right tools to track and prioritize the shift from traditional monitoring to RBM, successful implementation is doubtful, posing detrimental consequences not only for the monitors, but also the overall trial.
Navigating the many complexities in clinical trials, manufacturing, and regulatory interaction in moving gene therapies from development to market.
How iterative analysis of subject recruitment data can optimize outcomes during ongoing enrollment.
In the clinical development setting, most organizations are already working in an electronic world but still thinking in "paper."
The last decade has seen the complexity, size, and costs of clinical trials increase, which has made the task of guaranteeing data quality progressively difficult.
Centralized monitoring offers sponsors and CROs the program-wide oversight they need to successfully develop the medications of the future, says CluePoints CEO, Francois Torche.
Expect the FDA to be looking at a new metric in the drug approval process: driving safety.
How iterative analysis of subject recruitment data can optimize outcomes during ongoing enrollment.